title: Induction, regulation and messenger half-life of cytochromes P450 IA1, IA2 and IIIA6 in primary cultures of rabbit hepatocytes. CYP 1A1, 1A2 and 3A6 chromosome location in the rabbit and evidence that post-transcriptional control of gene IA2 does not involve mRNA stabilization.
abstract: A study on the regulation and induction of expression of cytochromes P450-IA1, IA2 and IIIA6 genes has been undertaken using primary cultures of adult rabbit hepatocytes grown in a serum-free chemically and hormonally defined medium. In 72-h-old cultures, 50 microM beta-naphthoflavone induced both IA1 and IA2 mRNA, the maximal level being reached after 4 h and 12 h, respectively. This was shown to result from an increase in the rate of transcription of gene IA1. In contrast, gene IA2 was constitutively transcribed in untreated cells, but mRNA only accumulated in the presence of beta-naphthoflavone which, however, did not affect the rate of transcription. Actinomycin D fully blocked induction of both IA1 and IA2 mRNA in response to their inducer. In untreated cells the presence of cycloheximide allowed a 'constitutive' expression of gene IA1, while in beta-naphthoflavone-treated cells, it produced a super-induction of IA1 but no modification of IA2 gene expression. Rifampicin (50 microM) strongly increased the IA1 mRNA level and rate of transcription only in cycloheximide-treated cells. Rifampicin and dexamethasone, two prototypical inducers of P450-IIIAs, induced both large and small IIIA6 mRNAs in a time-dependent fashion, the maximum level being reached after 24 h. This was related to a large increase in the rate of transcription of the gene. Cycloheximide significantly decreased the accumulation of both IIIA6 mRNAs in response to rifampicin, while actinomycin D fully blocked induction. The half-lives of IA1, IA2 and IIIA6 mRNAs were determined by two different methods, namely actinomycin D and [3H]uridine-chase experiments. In untreated cells, the half-lives for IA1, IA2 and IIIA6 mRNAs were 14 h, 16 h and 19 h, respectively when determined by the uridine chase and 18 h, 25 h and 22 h when determined by the actinomycin-D chase. These values were not modified significantly in cells treated with beta-naphthoflavone or rifampicin, indicating that neither of these inducers affected the stability of IA1 and IA2 or IIIA6 messages, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
authors.affiliation: INSERM U-128, CNRS, Montpellier, France.
authors.forename: M
authors.initials: M
authors.lastname: Daujat
authors.forename: P
authors.initials: P
authors.lastname: Clair
authors.forename: C
authors.initials: C
authors.lastname: Astier
authors.forename: I
authors.initials: I
authors.lastname: Fabre
authors.forename: T
authors.initials: T
authors.lastname: Pineau
authors.forename: M
authors.initials: M
authors.lastname: Yerle
authors.forename: J
authors.initials: J
authors.lastname: Gellin
authors.forename: P
authors.initials: P
authors.lastname: Maurel
mesh_terms: D000818:Animals; D001571:Benzoflavones / Q000494:pharmacology; D015152:Blotting, Northern; D002478:Cells, Cultured; D002874:Chromosome Mapping; D003513:Cycloheximide / Q000494:pharmacology; D019388:Cytochrome P-450 CYP1A2; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D004247:DNA / Q000235:genetics; D003609:Dactinomycin / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects; D006207:Half-Life; D008099:Liver / Q000201:enzymology*; D010088:Oxidoreductases / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D010957:Plasmids; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000378:metabolism*; D011817:Rabbits; D012293:Rifampin / Q000494:pharmacology; D019324:beta-Naphthoflavone
chemical_list: D001571:Benzoflavones; D012333:RNA, Messenger; D003609:Dactinomycin; D019324:beta-Naphthoflavone; D003907:Dexamethasone; D004247:DNA; D003577:Cytochrome P-450 Enzyme System; D003513:Cycloheximide; D010088:Oxidoreductases; D019388:Cytochrome P-450 CYP1A2; D012293:Rifampin